At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

18 May 2021
Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with...
Lonza launches next-generation 4D-Nucleofector® Platform, the leading non-viral cell transfection method for a wide variety of cell types – even those traditionally hard to...
23 May 2022
Lonza to Expand Inhalation Capabilities at Tampa Site
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of continued focus on providing bioavailability enhancement series for global...
05 May 2022
Lonza Announces Results of the 2022 Annual General Meeting – All Motions...
Shareholders re-elected all existing members of the Board of Directors who stood for re-election and elected Marion Helmes and Roger Nitsch as new members of the Board of...